Lv4
770 积分 2022-05-09 加入
CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance
7天前
已完结
Targeting glycosylation to enhance tumor immunotherapy
10天前
已完结
Short Mucin-Type O -Glycans in Cancer: Biomarker and Therapeutic Potential amid Analytical Barriers
10天前
已完结
Diagnostic Potential of Tn-MUC1 in Breast Cancer: A Novel Immunohistochemical Marker Reflecting Tumor Progression
13天前
已完结
Molecular alterations of muc1 and their therapeutic exploitation: Emerging opportunities in cancer therapy
21天前
已完结
The Importance of Treatment Timing and Positioning in IBD
1个月前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
5个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
5个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
5个月前
已完结
Prevalence and Trend of Biopsy-Proven IgA Nephropathy in China: A Systematic Review
5个月前
已完结
皖公网安备34019202002308
